Skip to main content
Top
Published in: Diagnostic Pathology 1/2017

Open Access 01-12-2017 | Case Report

Mesonephric adenocarcinoma of the uterine corpus with intracystic growth completely confined to the myometrium: a case report and literature review

Authors: Hiroka Ando, Yuko Watanabe, Minori Ogawa, Hiromi Tamura, Tomomi Deguchi, Kayo Ikeda, Mayumi Fujitani, Mitsunori Shioji, Tomoko Tsujie, Reiko Doi, Akinori Wakimoto, Shiro Adachi

Published in: Diagnostic Pathology | Issue 1/2017

Login to get access

Abstract

Background

Mesonephric adenocarcinoma (MA) is a rare tumor believed to arise from mesonephric remnants occurring mostly in the uterine cervix and, to a lesser extent, the corpus. Since the first case report of MA in the corpus in 1995, only 16 cases have been reported in the English literature. A recent report suggested that MA originates in Müllerian tissue and exhibits the mesonephric differentiation phenotype.

Case presentation

An asymptomatic 61-year-old woman was referred to our hospital because of elevated levels of tumor markers. Imaging revealed an intramural lesion of the uterine corpus exhibiting fluorodeoxyglucose uptake. A total hysterectomy and bilateral salpingo-oophorectomy were performed. The tumor was completely confined to the corpus wall and was composed of an intracystic bulky component and an invasive component in the myometrial layer. The tumor exhibited a variety of growth patterns, including a characteristic tubular pattern with dense eosinophilic secretion reminiscent of the thyroid, as well as a variety of morphologies, such as acinar, papillary, and ductal structures. The structures were immunoreactive for CK7, vimentin, CD10, calretinin, PAX8, and GATA3 and almost completely negative for ER/PgR. CA125 and CA19–9 antigen expression was also detected.

Conclusion

A case of MA with a unique growth pattern of an intracystic mass within the corpus wall is presented. The histogenesis and differential diagnoses are discussed. The histogenesis of MA is not yet clear. We hypothesize two different pathways involved: 1) direct development from the mesonephric remnants and/or 2) mesonephric transformation of Müllerian adenocarcinoma.
Literature
1.
go back to reference Ferry JA, Scully RE. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases. Am J Surg Pathol. 1990;14:1100–11.CrossRefPubMed Ferry JA, Scully RE. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases. Am J Surg Pathol. 1990;14:1100–11.CrossRefPubMed
2.
go back to reference Yamamoto Y, Akagi A, Izumi K, Kishi Y. Carcinosarcoma of the uterine body of mesonephric origin. Pathol Int. 1995;45:303–9.CrossRefPubMed Yamamoto Y, Akagi A, Izumi K, Kishi Y. Carcinosarcoma of the uterine body of mesonephric origin. Pathol Int. 1995;45:303–9.CrossRefPubMed
3.
go back to reference Ordi J, Nogales FF, Palacin A, Márquez M, Pahisa J, Vanrell JA, et al. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation. Am J Surg Pathol. 2001;25:1540–5.CrossRefPubMed Ordi J, Nogales FF, Palacin A, Márquez M, Pahisa J, Vanrell JA, et al. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation. Am J Surg Pathol. 2001;25:1540–5.CrossRefPubMed
4.
go back to reference Bagué S, Rodríguez IM, Prat J. Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases. Am J Surg Pathol. 2004;28:601–7.CrossRefPubMed Bagué S, Rodríguez IM, Prat J. Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases. Am J Surg Pathol. 2004;28:601–7.CrossRefPubMed
5.
go back to reference Marquette A, Moerman P, Vergote I, Amant F. Second case of uterine mesonephric adenocarcinoma. Int J Gynecol Cancer. 2006;16:1450–4.CrossRefPubMed Marquette A, Moerman P, Vergote I, Amant F. Second case of uterine mesonephric adenocarcinoma. Int J Gynecol Cancer. 2006;16:1450–4.CrossRefPubMed
6.
go back to reference Wani Y, Notohara K, Tsukayama C. Mesonephric adenocarcinoma of the uterine corpus: a case report and review of the literature. Int J Gynecol Pathol. 2008;27:346–52.CrossRefPubMed Wani Y, Notohara K, Tsukayama C. Mesonephric adenocarcinoma of the uterine corpus: a case report and review of the literature. Int J Gynecol Pathol. 2008;27:346–52.CrossRefPubMed
7.
go back to reference Kenny SL, McBride HA, Jamison J, McCluggage WG. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β. Am J Surg Pathol. 2012;36:799–807.CrossRefPubMed Kenny SL, McBride HA, Jamison J, McCluggage WG. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β. Am J Surg Pathol. 2012;36:799–807.CrossRefPubMed
8.
go back to reference Wu H, Zhang L, Cao W, Hu Y, Liu Y. Mesonephric adenocarcinoma of the uterine corpus. Int J Clin Exp Pathol. 2014;7:7012–9.PubMedPubMedCentral Wu H, Zhang L, Cao W, Hu Y, Liu Y. Mesonephric adenocarcinoma of the uterine corpus. Int J Clin Exp Pathol. 2014;7:7012–9.PubMedPubMedCentral
9.
go back to reference McFarland M, Quick CM, McCluggage WG. Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas. Histopathology. 2016;68:1013–20.CrossRefPubMed McFarland M, Quick CM, McCluggage WG. Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas. Histopathology. 2016;68:1013–20.CrossRefPubMed
10.
go back to reference Kim SS, Nam JH, Kim G-E, Choi YD, Choi C, Park CS. Mesonephric Adenocarcinoma of the uterine corpus: a case report and diagnostic pitfall. Int J Surg Pathol. 2016;24:153–8.CrossRefPubMed Kim SS, Nam JH, Kim G-E, Choi YD, Choi C, Park CS. Mesonephric Adenocarcinoma of the uterine corpus: a case report and diagnostic pitfall. Int J Surg Pathol. 2016;24:153–8.CrossRefPubMed
11.
go back to reference Kurman RJ, Ronnett BM, WE SME. Tumors of the cervix, vagina, and vulva. AFIP atlas tumor Pathol. Ser. 4. Washington, DC: American Registry of Pathology; 2010. p. 191–7. Kurman RJ, Ronnett BM, WE SME. Tumors of the cervix, vagina, and vulva. AFIP atlas tumor Pathol. Ser. 4. Washington, DC: American Registry of Pathology; 2010. p. 191–7.
12.
go back to reference Kurman RJ, Ronnett BM, WE SME. Tumors of the cervix, vagina, and vulva. AFIP atlas tumor Pathol. Ser. 4. Washington, DC: American Registry of Pathology; 2010. p. 273. Kurman RJ, Ronnett BM, WE SME. Tumors of the cervix, vagina, and vulva. AFIP atlas tumor Pathol. Ser. 4. Washington, DC: American Registry of Pathology; 2010. p. 273.
13.
go back to reference Clement PB, Young RH, Keh P, Ostör AG, Scully RE. Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component. Am. J Surg Pathol. 1995;19:1158–71.CrossRef Clement PB, Young RH, Keh P, Ostör AG, Scully RE. Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component. Am. J Surg Pathol. 1995;19:1158–71.CrossRef
14.
go back to reference Nogales FF, Bocian J, Meeks G, Clay-Frick H, Richart R, Dazza F, et al. Mesonephric (Wolffian) tumours of the female genital tract: is mesonephric histogenesis a mirage and trap? Curr Diagnostic Pathol. 1995;2:94–100.CrossRef Nogales FF, Bocian J, Meeks G, Clay-Frick H, Richart R, Dazza F, et al. Mesonephric (Wolffian) tumours of the female genital tract: is mesonephric histogenesis a mirage and trap? Curr Diagnostic Pathol. 1995;2:94–100.CrossRef
15.
go back to reference Howitt BE, Emori MM, Drapkin R, Gaspar C, Barletta JA, Nucci MR, et al. GATA3 is a sensitive and specific marker of benign and malignant Mesonephric lesions in the lower female genital tract. Am J Surg Pathol. 2015;39:1411–9.CrossRefPubMed Howitt BE, Emori MM, Drapkin R, Gaspar C, Barletta JA, Nucci MR, et al. GATA3 is a sensitive and specific marker of benign and malignant Mesonephric lesions in the lower female genital tract. Am J Surg Pathol. 2015;39:1411–9.CrossRefPubMed
16.
go back to reference Clark BZ, Beriwal S, Dabbs DJ, Bhargava R. Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas. Am J Clin Pathol. 2014;142:64–71.CrossRefPubMed Clark BZ, Beriwal S, Dabbs DJ, Bhargava R. Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas. Am J Clin Pathol. 2014;142:64–71.CrossRefPubMed
Metadata
Title
Mesonephric adenocarcinoma of the uterine corpus with intracystic growth completely confined to the myometrium: a case report and literature review
Authors
Hiroka Ando
Yuko Watanabe
Minori Ogawa
Hiromi Tamura
Tomomi Deguchi
Kayo Ikeda
Mayumi Fujitani
Mitsunori Shioji
Tomoko Tsujie
Reiko Doi
Akinori Wakimoto
Shiro Adachi
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2017
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-017-0655-y

Other articles of this Issue 1/2017

Diagnostic Pathology 1/2017 Go to the issue